Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells
Anticancer Research · 2026
DOI: 10.21873/anticanres.18119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Patricia Augustine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry and Biochemistry Department, University of the Incarnate Word, San Antonio, TX, U.S.A. Hauptthemen laut MEDLINE: Repressor Proteins, Hedgehog Proteins, Breast Neoplasms, Nuclear Proteins.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry and Biochemistry Department, University of the Incarnate Word, San Antonio, TX, U.S.A.
- Biology Department, University of the Incarnate Word, San Antonio, TX, U.S.A.
- Biology Department, University of the Incarnate Word, San Antonio, TX, U.S.A. mburleso@uiwtx.edu.
Zitieren
APA
Augustine, P., Chavarria, J., & Burleson, M. (2026). Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.18119
Vancouver
Augustine P, Chavarria J, Burleson M. Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells. Anticancer Research. 2026. doi:10.21873/anticanres.18119
BibTeX
@article{Augustine2026,
author = {Augustine, Patricia and Chavarria, Jazmin and Burleson, Marieke},
title = {Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18119}
}
EUVIMED